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Abstract
Given the social importance of intracranial aneurysm as a major cause of a lethal subarach-
noid hemorrhage, clarification of mechanisms underlying the pathogenesis of this disease is
essential for improving poor prognosis once after rupture. Previous histopathological analy-
ses of human aneurysm walls have revealed the presence of T cells in lesions suggesting
involvement of this type of cell in the pathogenesis. However, it remains unclear whether T
cell actively participates in intracranial aneurysm progression. To examine whether T cell is
involved in aneurysm progression, intracranial aneurysm model of rat was used. In this
model, aneurysm is induced by increase in hemodynamic force loaded on bifurcation site of
intracranial arteries where aneurysms are developed. Deficiency in T cells and pharmaco-
logical inhibition of T cell function were applied to this model. CD3-positive T cells were pres-
ent in human aneurysm walls, whose number was significantly larger compared with that in
control arterial walls. Deficiency in T cells in rats and pharmacological inhibition of T cell
function by oral administration of Cyclosporine A both failed to affect intracranial aneurysm
progression, degenerative changes of arterial walls and macrophage infiltration in lesions.
Although T cells are detectable in intracranial aneurysm walls, their function is dispensable
for macrophage-mediated inflammation and degenerative changes in arterial walls, which
presumably leads to intracranial aneurysm progression.
Introduction
Subarachnoid hemorrhage attributable to rupture of intracranial aneurysms (IAs) has a poor-
est prognosis among all type of stroke in spite of recent diagnostic and therapeutic advances; a
mortality rate of 50% and significant disabling effect in 50% of survivors [1, 2]. IA is a common
pathology in intracranial arteries with a prevalence of 2–4% [3] in general public, and many
IAs are indeed incidentally detected through MRI examination or some other modalities
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before rupture [4–6]..Nonetheless, currently, prevention of rupture of such incidentally found
IAs is confined to surgical interventions like microsurgical clipping. However, because of
the intrinsic risk of complication associated with surgical manipulations, interventions are
performed only in less than half of cases with unruptured IAs [5]. Given the poor outcome due
to subarachnoid hemorrhage after rupture of IAs and nature of unruptured IAs as an asymp-
tomatic lesion, noninvasive prophylactic methods to treat IAs before rupture are socially
demanded. Thereby, better understanding of the pathogenesis of IAs is essential. Recent accu-
mulating evidence has established the notion that IA is a chronic inflammatory disease in
intracranial arteries and macrophage plays a crucial role in the pathogenesis of IAs through
regulating such inflammatory responses in lesions [7–11].
Histopathological studies of human IAs and IAs induced in experimental models have
revealed the presence of T cells as second most abundant type of cells next to macrophage in
lesions [12–14]. Further, Frosen et al. demonstrated that number of T cells infiltrated in walls
of ruptured IAs is larger than those in unruptured IAs [15], indicating the association of T
cells to rupture. Although T cell becomes a major constituent element that regulates immune
and inflammatory responses in microenvironment of acquired immunity and thus contributes
to the pathogenesis of variety of inflammatory or immune diseases, contribution of T cells to
the pathogenesis of IAs and, if there is, how remains to be elucidated.
The aim of this study is to clarify whether T cell contributes to IA formation and progres-
sion by using rat model of IAs in combination with depletion of T cell or pharmacological
inhibition of its function.
Materials and methods
Rodent IA models and histological analysis of induced IA
All of the following experiments, including animal care and use, complied with the National
Institute of Health’s Guide for the Care and Use of Laboratory Animals and were approved by
the Institutional Animal Care and Use Committee of Kyoto University Graduate School of
Medicine.
Male F344/NJcl-rnu/rnu rats, which have a mutation in Whn gene resulting in absence of
thymus and defect in T cells [16], and their wild type control, F344/Jcl rats, were purchased
from Japan CLEA (Tokyo, Japan). Animals were maintained on a light/dark cycle of 14 h/10 h,
and had a free access to chow and water. To induce IA, 7-week-old male rats were anesthetized
by intraperitoneal injection of pentobarbital sodium (50 mg/kg) and subjected to ligation of
the left carotid artery and systemic hypertension achieved by the combination of salt overload-
ing and ligation of the left renal artery [17]. This surgical procedure is defined as the ‘aneurysm
induction’. Immediately after the surgical manipulation, animals were fed a chow containing
8% sodium chloride. In a chow, 0.12% 3-aminopropionitrile (Tokyo Chemical Industry,
Tokyo, Japan), an inhibitor of lysyl oxidase that catalyzes the cross-linking of collagen and elas-
tin, was added to facilitate IA formation and progression [17]. Systemic blood pressure was
measured by the tail-cuff method without any anesthesia and its value was calculated as a
mean of independent 3 measurements per animal. At time points indicated in the correspond-
ing Figure legends or Results after the aneurysm induction, animals were deeply anesthetized
by intraperitoneal injection with a lethal dose of pentobarbital sodium, and transcardially per-
fused with the fixative, 4% paraformaldehyde. The right anterior cerebral artery (ACA) and
olfactory artery (OA) bifurcation including the IA lesion was then stripped and serial frozen
sections were prepared. IA induction, area of induced IAs and length between disrupted por-
tion of internal elastic lamina at this bifurcation were histopathologically examined after Elas-
tica van Gieson staining.
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Immunohistochemistry
Animals were sacrificed and serial frozen sections with 5 μm thickness were prepared as same.
For immunohistochemistry, after blocking with 3% donkey serum (Jackson ImmunoResearch,
Baltimore, MD), the sections were incubated with primary antibodies followed by incubation
with secondary antibodies conjugated with fluorescent dye (Jackson ImmunoResearch).
Finally, immunofluorescence images were acquired on a confocal fluorescence microscope
system (Lsm-710, Carl Zeiss Microscopy GmBH, Gottingen, Germany).
Primary antibodies used are following; mouse monoclonal anti-smooth muscle alpha actin
(α-SMA) antibody (#MS113, Thermo scientific, Waltham, MA), mouse monoclonal anti-
CD68 antibody (#ab31630, Abcam, Cambridg, MA), rabbit polyclonal anti-matrix metallopro-
teinase (MMP) 9 antibody (#AB19016, Chmeicon, Temecula, CA), mouse monoclonal anti-
CD3 antibody (#M7254, DAKO, Carpinteria, CA).
Macrophage was defined as a CD68-positive cell in immunohistochemistry. Thickness of
media was defined as a ratio of the thickness of the thinnest portion in media, visualized by
immunostaining for α-SMA, to that of the distal normal arterial wall.
Cyclosporine A treatment
Cyclosporine A was purchased from Toronto Research Chemicals (#C988900, Ontario, Can-
ada). Cyclosporine A was dissolved in olive oil to a final concentration and orally administered
to rat IA models once a day. This dose of Cyclosporine A administered was determined by the
preliminary experiment, in which Concanavalin A-induced increase in IL-2 concentration in
plasma was suppressed by treatment with each dose of Cyclosporine A. Rats treated with
Cyclosporine A were sacrificed at 14th day after the aneurysm induction and sections of IAs
induced at right ACA-OA bifurcation were prepared for further analyses.
Primary culture of Bone marrow-derived macrophage (BMM)
Bone marrow cells were collected from femur of male F344/Jcl or F344/NJcl-rnu/rnu rats and
cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 20% fetal bovine
serum (FBS) and macrophage-colony stimulating factor (M-CSF, 50 ng/ml, Peprotech, Rocky
Hill, NJ) to differentiate into macrophages for 7 days. Cells were then harvested for further
analysis.
Quantitative real time (RT)-PCR analysis
RNA purification from primary culture of macrophages and reverse transcription of purified
RNA were performed using a RNeasy Plus Mini Kit (QIAGEN, Hilden, Germany) and a
High-capacity cDNA Reverse Transcription Kit (Life Technologies Corporation, Carlsbad,
CA), according to manufacturers’ instructions. For the quantification of gene expression,
quantitative RT-PCR was performed on a Real Time System CFX96 (Bio-rad, Hercules, CA)
using a SYBR Premix Ex Taq II (TAKARA BIO INC., Shiga, Japan). β-actin was used as an
internal control. For quantification, the second derivative maximum method was used for
crossing point determination.
Primers used in the present experiment are listed in following; monocyte chemotactic pro-
tein-1 (MCP-1; Ccl2) forward 5’-TGCTGAAGTCCTTAGGGTTGATGC-3’ and reverse 5’-
GCAGCAGGTGTCCCAAAGAAGC-3’; tumor necrosis factor-alpha (TNF-r; Tnf) forward 5’-
CTCCTGGTATGAAGTGGCAAATCG-3’ and reverse 5’-TGGCATGGATCTCAAAGACAACC-
3’; cyclooxygenase-2 (COX-2; Ptgs2) forward 5’-TCAGTATGAGCCTGCTGGTTTGG-3’ and
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In Western Blot analysis, whole cell lysate was prepared from primary culture of macrophages
treated with indicated stimuli in the Results or Figure Legends by RIPA buffer (Sigma Aldrich,
St. Louis, MO) supplemented with proteinase and phosphatase inhibitors (Roche, Indianapo-
lis, IN). After Sodium Dodecyl Sulfate- Polyacrylamide gel Electrophoresis (SDS-PAGE), sepa-
rated proteins were transferred to a PVDF membrane (Immobilon-P, Merck) and blocked
with an ECL plus blocking agent (GE healthcare, Buckinghamshire, UK). Blotted membranes
were, then, incubated with primary antibodies followed by incubation with anti-IgG antibody
conjugated with horseradish peroxidase (GE healthcare). Finally, the signal was detected by
the chemiluminescent reagent (ECL Prime Western Blotting Detection System, GE health-
care). α-Tubulin was served as an internal control.
Primary antibodies used in this study are as follows: rabbit monoclonal anti-p65 antibody
(Cell Signaling Technology, Danvers, MA), rabbit monoclonal anti-phospho NF-κB p65
(ser536) antibody (Cell Signaling Technology), mouse monoclonal anti-IκBα antibody (Cell
Signaling Technology), mouse monoclonal anti-α-tubulin antibody (Sigma Aldrich).
Phagocytic activity of BMM
BMM prepared as described above were cultured with an iron-containing nanoparticle (feru-
moxytol, AMAG Pharmaceuticals, Inc., Waltham, MA) for 24 h. Cells were then fixed and
iron engulfed by BMM was detected after Berlin blue staining.
Human IA specimen and immunohistochemistry
Human IA samples and control arteries (middle meningeal artery or superficial temporal
artery) were obtained during neck clipping of IAs with written informed consent. The use of
human IAs in research was approved by the local ethical committee at Kyoto University Grad-
uate School of Medicine and also at Japan Red Cross Asahikawa Hospital.
Dissected specimen of IAs and control arterial walls were fixed in formalin solution and
embedded in paraffin. Slices with 4 μm thickness were then prepared for immunohistochemi-
cal analysis. Immunohistochemistry was done same as described in the previous section after
deparaffinization.
Primary antibodies used are: mouse monoclonal anti-human CD3 antibody (#NCL-
CD3-PS1, Leica Biosystems, Wetzlar, Germany), mouse monoclonal anti-human CD4 anti-
body (#NCL-CD4-1F6, Leica Biosystems), mouse monoclonal anti-human CD8 antibody
(#M7103, Dako).
Statistical analysis
Data are shown as the mean ± SEM, and 2 groups were statistically compared using the
Mann−Whitney U test. A p value smaller than 0.05 was defined as statistically significant.
Results
Infiltration of T cells in human IA lesions
First, we wished to confirm and reproduce the previously reported findings that T cells are
present and accumulated in human IA lesions [12, 13]. We therefore collected 5 human IA
lesions and 2 control arterial walls (superficial temporal artery or middle meningeal artery)
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and immunostained sections from these specimens using an anti-CD3 antibody. In all IA walls
examined, signals positive for CD3 were detectable as ones scattered in media and adventitia
(27.3 ± 8.9 cells / high-power field (HPF, 56,000 μm2), 5 fields / section, n = 5) as contrasted
with those in control arterial walls, in which signals were almost absent (0.2 ± 0.1 cells / HPF,
5 fields / section, n = 2) (Fig 1). We next characterized a subset of T cells infiltrated in IA walls
and found that CD3-positive T cells present in IA walls included both CD4-positive and
CD8-positive T cell subsets and their number was not significantly different (CD4; 6.8 ± 3.2
cells / HPF, CD8; 11.3 ± 3.7 cells / HPF) (Fig 1B and 1C). Noted that number of CD3-, CD4-
and CD8-positive T cells was all significantly increased in IA lesions compared with control
arterial walls (CD3; p<0.001, CD4; p = 0.047, CD8; p<0.001), suggesting the role of T cell
function in IA formation and progression.
Involvement of T cell function in IA formation and progression examined
by using T cell-deficient F344/NJcl-rnu/rnu rats
Next, to examine whether T cells are involved in the pathogenesis of IA formation and pro-
gression and, if so, how, we used a rat strain deficient in T cells due to a mutation in Whn
gene, a F344/NJcl-rnu/rnu rat [16], and a F344/Jcl rat as a wild type control. First, we con-
firmed that CD3-positive T cell was indeed absent in F344/NJcl-rnu/rnu rat in immunohis-
tochemistry using the spleen from this rat strain as a specimen and that from F344/Jcl rat as a
wild type control (Fig 2A). We then subjected these rat strains to IA model and evaluated
whether T cell deficiency affected IA formation and progression. IA defined as a lesion with
disrupted internal elastic lamina was induced in all rats examined independent of genotype.
Both strains of rats, a F344/Jcl and a F344/NJcl-rnu/rnu rat, showed similar IA progression
after the aneurysm induction examined by area of induced IAs (F344/Jcl rat; 232.6 ± 102.3,
385.9 ± 40.1, 1551.4 ± 200.1 μm2 for day 7 (n = 8), 28 (n = 8), or day 56 (n = 8), respectively,
F344/NJcl-rnu/rnu rat; 379.9 ± 254.2, 395.5 ± 140.8, 1572.2 ± 421.0 μm2 for day 7 (n = 7), 28
Fig 1. Accumulation of T cells in human unruptured IA walls. (A, B) Accumulation of CD3-, CD4- and
CD8-positive T cells in human unruptured IA walls. Adjacent sections were prepared from branches of carotid
artery (Control) or unruptured IA lesion (Aneurysm) of humans and immunostained for a T cell marker, CD3,
or subset specific makers, CD4 and CD8, respectively. Box in (A) indicates the region magnified in the
following panels shown in (B). Bar, 100 μm. (C) Number of CD3-, CD4- and CD8-positive T cells in control
arterial walls and IA walls. Data represents mean ± SEM (n = 10 in control, n = 15 in aneurysm). *, p<0.05,
**, p<0.01 in a Mann−Whitney U test. Noted the significant increase in both CD4- and CD8-positive T cells in
IA walls compared with those in control arterial walls.
https://doi.org/10.1371/journal.pone.0175421.g001
T cell does not contribute to IA progression
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Fig 2. Effect of T cell deficiency on IA progression. (A) Deficiency in T cells in a F344/NJcl-rnu/rnu rat.
Sections prepared from spleen from a T cell-deficient F344/NJcl-rnu/rnu rat and a wild type F344/Jcl were
immunostained for a T cell marker, CD3. Images from immunostaining for CD3 (green), a nuclear staining
DAPI (blue) and merged images are shown. Bar, 20 μm. Noted the deficiency in CD3-positive T cells in a
F344/NJcl-rnu/rnu rat. (B-G) Independence of IA progression, systemic blood pressure, degenerative
changes and macrophage infiltration in lesions from deficiency in T cells. F344/NJcl-rnu/rnu rats and F344/Jcl
rats were subjected to IA induction and, at indicated days (7th, 28th and 56th) after the induction, slices from IA
specimen induced at an anterior cerebral-olfactory artery (ACA-OA) bifurcation were prepared for further
analyses. Systemic blood pressure was evaluated before sacrifice without any anesthesia and mean from 3
independent measurements was calculated (D). Area of induced IAs (F344/Jcl: day 7 (n = 8), 28 (n = 8), or
day 56 (n = 8); F344/NJcl-rnu/rnu: day 7 (n = 7), 28 (n = 7), or day 56 (n = 7)) (C) and distance between
disrupted internal elastic lamina (IEL) in lesions (F344/Jcl: n = 8, F344/NJcl-rnu/rnu: n = 7, day 56) (E) were
evaluated after Elastica van Gieson (EvG) staining (Representative images are shown in B). Degenerative
change in IA walls was assessed by thickness of medial smooth muscle cell layer after immunostaining for α-
smooth muscle actin, a smooth muscle cell marker (F344/Jcl: n = 8, F344/NJcl-rnu/rnu: n = 7, day 56) (F).
Number of infiltrated macrophages in IA lesions was evaluated after immunostaining for a macrophage
marker CD68 (F344/Jcl: n = 8, F344/NJcl-rnu/rnu: n = 7, day 56, cell count per 12,100 μm2). Data represents
mean ± SEM. (H) MMP9 expression in IA lesion from both strains. Slices of induced IA lesions from both
strains were prepared as above at day 7 after the induction and subjected to immunostaining for MMP9.
Images from immunostaining for MMP9 (red), a nuclear staining DAPI (blue) and merged images are shown.
Bar, 20 μm in (B), 10 μm in (H). Noted that there are not any differences identified in either evaluation between
T cell-deficient- and wild type rats.
https://doi.org/10.1371/journal.pone.0175421.g002
T cell does not contribute to IA progression
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(n = 7), or day 56 (n = 7), respectively) (Fig 2B and 2C). Since IA formation and progression in
rodent IA model is influenced by systemic blood pressure [18, 19], systemic blood pressure at
each time point was evaluated and there was no significant difference (Fig 2D). Consistently,
deficiency of T cells in rats did not affect degenerative changes in IA walls, disruption of inter-
nal elastic lamina examined by Elastica van Gieson staining (F344/Jcl rat; 65.5 ± 8.9 μm, n = 8,
F344/NJcl-rnu/rnu rat; 59.2 ± 5.8 μm, n = 7) and thinning of media evaluated by immunos-
taining for α-SMA, at 56th day after the induction (F344/Jcl rat; 2.9 ± 0.3 μm, n = 8, F344/NJcl-
rnu/rnu rat; 3.3 ± 0.4 μm, n = 7) (Fig 2E and 2F). Macrophage is a major inflammatory cell in
IA lesions and plays a crucial role in formation and progression of the disease [7–10]. Thereby,
we examine infiltration of CD68-positive macrophages in IA lesions in immunohistochemis-
try. As expected from the similar progression of IAs and similar degeneration of arterial walls
in IAs induced in F344/NJcl-rnu/rnu rats (Fig 2B–2F), number of infiltrated macrophages in
lesions was not affected by deficiency in T cells (F344/Jcl rat; 1.0 ± 0.3 cells / HPF, n = 8, F344/
NJcl-rnu/rnu rat; 0.9 ± 0.2 cells / HPF, n = 7) (Fig 2G). Consistently, expression of facilitating
factor of IA progression secreted from macrophages, MMP9 [7, 14], was not changed in IA
lesions from F344/NJcl-rnu/rnu rats compared with those from control F344/Jcl rats (Fig 2H).
As macrophage plays a crucial role in IA formation and progression [7–10], we wished to
confirm that deficiency in T cells in F344/NJcl-rnu/rnu rats was indeed dispensable for func-
tion/activation of macrophages. To address this issue, we prepared BMMs from a F344/NJcl-
rnu/rnu rat and a control F344/Jcl rat and examined whether there are any differences in acti-
vation of macrophages between those prepared from these two rat stains. As a result, BMMs
from these two strains both showed a similar phagocytic activity examined by engulfment of
iron-containing nanoparticles, Ferumoxytol, followed by detection with Berlin Blue staining
(Fig 3A). Furthermore, BMMs from a F344/NJcl-rnu/rnu rat responded to stimulation with
LPS (1 μg/ml) to activate NF-κB, as evidence by stimulation-dependent degradation of IκBα
and increase in phosphorylation of NF-κB p65 subunit, (Fig 3B) and to induce genes of pro-
inflammatory factors related with the pathogenesis of IAs, MCP-1 (Ccl2) [7, 8], TNF-α (Tnf)
[20–22], and COX-2 (Ptgs2) [23] (Fig 3C) in a similar manner with BMMs from a F344/Jcl rat.
Effect of pharmacological inhibition of T cell function on IA formation and
progression
To further corroborate our assumption that T cell function is dispensable for the pathogenesis
of IA, we administered an immunosuppressant, Cyclosporine A, to rat IA model and exam-
ined effect of pharmacological suppression of T cell function on IA formation and progression.
In this experiment, we adopted 15 mg/kg as a dose of Cyclosporine A used from the prelimi-
nary study in which administration of this compound suppressed Concanavalin A (15 mg/kg)
—induced increase in plasma concentration of IL-2 at a dose-dependent manner and at this or
more dose of Cyclosporine A such increase was completely ameliorated (Fig 4A). Cyclosporine
A (15 mg/kg) administered to rat model of IAs neither suppressed IA progression nor degen-
erative changes of arterial walls; thinning of media and disruption of internal elastic lamina
(Fig 4B). Furthermore, inflammation in lesions characterized by infiltration of macrophages
was not affected by Cyclosporine A treatment (Fig 4B). These results combined with findings
obtained from a T cell-deficient F344/NJcl-rnu/rnu rat strain suggest that T cell is dispensable
for the pathogenesis of IA progression.
Discussion
The pathological examination of human IA walls has revealed the presence of inflammatory
infiltrates, most typically macrophages and T cells [12–14], in lesions proposing the involvement
T cell does not contribute to IA progression
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of inflammation evoked by these infiltrating cells in the pathogenesis of IA formation and pro-
gression. Indeed, recent experimental studies have clarified the crucial contribution of macro-
phages recruited by their chemoattractant MCP-1 to these processes through mediating and
exacerbating inflammation [7, 8, 10, 11]. However, the central question whether T cells actively
participate in the pathogenesis of IAs and, if so, how they contribute to the pathogenesis remains
unsolved for about 20 years after the presence of T cells in IA lesions was histologically detected
and reported [12, 13]. In the present study, we addressed this remaining but important question
by subjecting T cell-deficient rats to IA models or pharmacological inhibition of T cell function
and demonstrated that T cell function is dispensable for IA formation and progression. As T
cells have distinct subsets and each subset sometimes oppositely functions, a subset-specific
depletion of T cells may reveal some contribution of a certain subset of T cells to the pathogene-
sis of IAs. Recently published report demonstrating the progressive bilateral fusiform intracra-
nial aneurysms in a child with human immunodeficiency virus/acquired immunodeficiency
syndrome, in which CD4-positive T cell subset is affected, indicates such a possibility [24].
Fig 3. Proper macrophage activation in a T cell-deficient F344/NJcl-rnu/rnu rat. Bone marrow
macrophages (BMMs) were prepared from a T cell-deficient F344/NJcl-rnu/rnu rat and a wild type F344/Jcl rat
as described in Materials and Methods in detail. Phagocytic activity (A) and response to inflammatory
stimulation with LPS (B, C) of BMMs prepared were then evaluated. To examine phagocytic activity, BMMs
from both strains were treated with iron-containing nanoparticles, Ferumoxytol, for 24 h and engulfed particles
were detected by Berlin blue staining (A). Bar, 20 μm. Response of BMMs from both strains to LPS was
assessed by Western blot analysis and RT-PCR analyses targeting NF-κB-regulated pro-inflammatory
genes. For Western blotting, BMMs were stimulated with LPS (1 μg/ml) for indicated time period and total cell
lysate prepared from these stimulated cells was subjected to Western blotting for IκBα, phosphorylated form
of p65 subunit (s536, p-p65) and p65 subunit to evaluate NF-κB activation, using Western blotting for α-tubulin
as an internal control. For RT-PCR analyses, total RNA was purified from stimulated cells (LPS 0.1, 1, 10 μg/
ml, 60 min) and subjected to RT-PCR analyses for MCP-1 (Ccl2), TNF-α (Tnf) and COX-2 (Ptgs2) after
reverse transcription. Data represents mean ± SEM (n = 4). Noted that BMMs from a T cell-deficient rat shows
a similar phagocytic activity and properly responses to inflammatory stimulation as in a wild type BMMs.
https://doi.org/10.1371/journal.pone.0175421.g003
T cell does not contribute to IA progression
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Recently, Sawyer et al. also reported the similar observation with us in mouse IA model [25]. In
their report, they subjected mice deficient in T cells (Rag1-/-) to IA models, in which IAs were
induced by surgical manipulations similar with our models, and found that T cell deficiency did
not affect IA formation[25] as in our results using a T cell-deficient rat model, supporting our
Fig 4. Effect of a pharmacological inhibition of a T cell function on IA progression. (A) Dose-dependent
suppression of Concanavalin A-induced IL-2 production by Cyclosporine A in vivo. F344/Jcl rats were treated
with each dose of Concanavalin A (n = 3) or Cyclosporine A combined with 15 mg/kg Concanavaline A (n = 3).
Before administration (pre) or after 3 h (post), serum samples were prepared from rats and IL-2 concentration
in these samples was examined by ELISA. Noted that 15 mg/kg Cyclosporine A almost completely suppressed
Concanavalin A-induced IL-2 production. (B) Failure of suppression of IA progression, degenerative changes
and infiltration of macrophages in lesions by treatment with Cyclosporine A. F344/Jcl rats were subjected to IA
induction and, at 14th day after the induction, slices from IA specimen induced at ACA-OA bifurcation were
prepared for further analyses. Administration of Cyclosporine A was started 1 day before the induction and
lasted for a whole experimental period (15 mg/kg, once a day). Systemic blood pressure was evaluated before
sacrifice without any anesthesia. Area of induced IAs (Vehicle; n = 8, Cyclosporine A; n = 8) and distance
between disrupted internal elastic lamina (IEL) in lesions were evaluated after Elastica van Gieson (EvG)
staining (Representative images are shown in upper left panels). Degenerative change in IA walls was
assessed by thickness of medial smooth muscle cell layer after immunostaining for α-smooth muscle actin.
Number of infiltrated macrophages in IA lesions was evaluated after immunostaining for a macrophage marker
CD68 (per 12,100 μm2). Data represents mean ± SEM. Representative images of immunostaining for CD68
(green) and α-smooth muscle actin (α-SMA, red) and of nuclear staining DAPI (blue) are shown in lower left
panels. Bar, 20 μm.
https://doi.org/10.1371/journal.pone.0175421.g004
T cell does not contribute to IA progression
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notion that macrophages not T cells regulate the pathogenesis of IAs. Thus, findings of the pres-
ent study have again highlighted the importance of macrophages as the major type of cells regu-
lating inflammatory responses leading to IA formation and progression. Atherosclerosis is
presumably one of the most important and common vascular diseases in society. Both IAs and
atherosclerosis share the common pathogenesis as a chronic inflammatory disease in arterial
walls [11, 26]. The contribution of T cells to disease development and progression, however,
may be completely different. In atherosclerosis, T cells, especially a CD4-positive T cell subset,
actively participate in its pathogenesis; i.e. Th1 cells play a proatherogenic role but regulatory
T cells behave atheroprotective[27–30], suggesting presence of completely different regulation
of inflammatory responses between these two vascular diseases. Now, IA is defined as a macro-
phage-mediated chronic inflammatory disease of intracranial arteries. This concept is pivotal
not only for our understanding of the pathogenesis of IAs but also for developing a novel diag-
nostic method to monitor inflammatory status of IA walls or a new drug therapy.
The major limitation of the present study is that we cannot assess the contribution of T cell-
mediated acquired immunity to rupture of IAs because the rupture rate of IAs induced in our
current model is not high enough to statistically analyze the influence of intrinsic or confound-
ing factors. To address such an imperative issue, a novel animal model, in which IAs harbor
the pathological similarity with human ones and spontaneously rupture at high rate, should be
established. Although careful interpretation is necessary regarding the clinical relevance of
their mouse IA model, Sawyer et al. demonstrated the suppression of rupture of IAs in mice
deficient in T cells [25], suggesting the involvement of T cells in mechanisms underlying rup-
ture of IAs. If so, there may be different pathogenesis between formation/progression and rup-
ture of IAs. In this point of view, contribution of each T cell subset, such as a CD4-positive T
cell, a CD8-positive T cell and a regulatory T cell, to rupture of IAs should be carefully exam-
ined. Nonetheless, given results from recent clinical studies that anti-inflammatory drugs such
as statins and NSAIDs effectively reduce incidence of subarachnoid hemorrhage [31, 32],
chronic inflammation in arterial walls may regulates the pathogenesis of IAs from initiation to
rupture even if the actively participating type of cells are different.
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